Balchem traded at $164.39 this Friday September 11th, decreasing $2.28 or 1.37 percent since the previous trading session. Looking back, over the last four weeks, Balchem lost 8.55 percent. Over the last 12 months, its price rose by 5.15 percent. Looking ahead, we forecast Balchem to be priced at 160.87 by the end of this quarter and at 150.76 in one year, according to Trading Economics global macro models projections and analysts expectations.
Balchem Corporation is engaged in developing, manufacturing, distributing and marketing of specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health (HNH) segment provides human grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. HNH segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. Its Animal Nutrition & Health (ANH) segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment sells ethylene oxide as a sterilant gas primarily for use in the healthcare industry.